# Directing stem cell differentiation by chromatin state approximation

**Authors:** Luis F Montano-Gutierrez, Sophie Müller, Ana P Kutschat, Igor Adameyko, Davide Seruggia, Florian Halbritter

PMC · DOI: 10.1093/nar/gkag124 · Nucleic Acids Research · 2026-02-25

## TL;DR

This paper introduces a new method to guide stem cell differentiation by comparing chromatin states, improving the efficiency of generating specific cell types like erythroblasts.

## Contribution

The novel approach uses chromatin state approximation to iteratively optimize differentiation protocols.

## Key findings

- Greedy selection based on chromatin approximation improves erythroblast differentiation in vitro.
- Analysis of chromatin regions reveals transcriptional regulators that hinder differentiation.
- Data-driven ligand selection enhances erythropoiesis efficiency.

## Abstract

A prime goal of regenerative medicine is to replace dysfunctional cells in the body. To design protocols for producing target cells in the laboratory, one may need to consider exponentially large combinations of culture components. Here, we investigated the potential of iteratively approximating the target phenotype by quantifying the distance between chromatin profiles (ATAC-seq) of differentiating cells in vitro and their in vivo counterparts. We tested this approach on the well-studied generation of erythroblasts from haematopoietic stem cells, evaluating a fixed number of components over two sequential differentiation rounds (8 × 8 protocols). We found that the most erythroblast-like cells upon the first round yielded the most erythroblast-like cells at the second round, suggesting that greedy selection by chromatin approximation can be a viable optimisation strategy. Furthermore, by analysing regulatory sequences in incompletely reprogrammed chromatin regions, we uncovered transcriptional regulators linked to roadblocks in differentiation and made a data-driven selection of ligands that further improved erythropoiesis. In future, our methodology can help craft notoriously difficult cells in vitro, such as B cells.

Graphical Abstract

## Full-text entities

- **Genes:** EPO (erythropoietin) [NCBI Gene 2056] {aka DBAL, ECYT5, EP, MVCD2}, PCSK9 (proprotein convertase subtilisin/kexin type 9) [NCBI Gene 255738] {aka FH3, FHCL3, HCHOLA3, LDLCQ1, NARC-1, NARC1}, IL4 (interleukin 4) [NCBI Gene 3565] {aka BCGF-1, BCGF1, BSF-1, BSF1, IL-4}, RPLP0 (ribosomal protein lateral stalk subunit P0) [NCBI Gene 6175] {aka L10E, LP0, P0, PRLP0, RPP0, uL10}, ARHGAP10 (Rho GTPase activating protein 10) [NCBI Gene 79658] {aka GRAF2, PS-GAP, PSGAP}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, IL3 (interleukin 3) [NCBI Gene 3562] {aka IL-3, MCGF, MULTI-CSF}, F3 (coagulation factor III, tissue factor) [NCBI Gene 2152] {aka CD142, TF, TFA}, FLT3 (fms related receptor tyrosine kinase 3) [NCBI Gene 2322] {aka CD135, FLK-2, FLK2, STK1}, COL9A3 (collagen type IX alpha 3 chain) [NCBI Gene 1299] {aka DJ885L7.4.1, EDM3, IDD, MED, STL6}, CD34 (CD34 molecule) [NCBI Gene 947], STAT1 (signal transducer and activator of transcription 1) [NCBI Gene 6772] {aka CANDF7, IMD31A, IMD31B, IMD31C, ISGF-3, STAT91}, ERG (ETS transcription factor ERG) [NCBI Gene 2078] {aka LMPHM14, erg-3, p55}, KITLG (KIT ligand) [NCBI Gene 4254] {aka DCUA, DFNA69, FPH2, FPHH, KL-1, Kitl}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, COMP (cartilage oligomeric matrix protein) [NCBI Gene 1311] {aka CTS2, EDM1, EPD1, MED, PSACH, THBS5}, MATN1 (matrilin 1) [NCBI Gene 4146] {aka CMP, CRTM}, TPO (thyroid peroxidase) [NCBI Gene 7173] {aka MSA, TDH2A, TPX}, CBX8 (chromobox 8) [NCBI Gene 57332] {aka PC3, RC1}, FLI1 (Fli-1 proto-oncogene, ETS transcription factor) [NCBI Gene 2313] {aka BDPLT21, EWSR2, FLI-1, SIC-1}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, Ms6hm (minisatellite 6 hypermutable) [NCBI Gene 17653] {aka PC-1}, ZNF394 (zinc finger protein 394) [NCBI Gene 84124] {aka ZKSCAN14, ZSCAN46}, KLF1 (KLF transcription factor 1) [NCBI Gene 10661] {aka CDAN4A, CDAN4B, EKLF, EKLF/KLF1}, COL9A2 (collagen type IX alpha 2 chain) [NCBI Gene 1298] {aka DJ39G22.4, EDM2, MED, STL5}
- **Diseases:** Cancer (MESH:D009369)
- **Chemicals:** HEP (MESH:D006493), hSCF (MESH:C571233), CO2 (MESH:D002245), steroid hormones (MESH:D013256), Hoechst 33342 (MESH:C017807), PI (MESH:D011419), 2.INS (-), penicillin (MESH:D010406), HCl (MESH:D006851), INS (MESH:D007328), testosterone (MESH:D013739), HYDRO (MESH:D006854), estradiol (MESH:D004958), streptomycin (MESH:D013307), methanol (MESH:D000432), NaCl (MESH:D012965), MgCl2 (MESH:D015636), phosphate (MESH:D010710)
- **Species:** Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** INS — Homo sapiens (Human), Embryonic stem cell (CVCL_XA15), HL60 — Homo sapiens (Human), Adult acute myeloid leukemia with maturation, Cancer cell line (CVCL_0002), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12956330/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12956330/full.md

## References

71 references — full list in the complete paper: https://tomesphere.com/paper/PMC12956330/full.md

---
Source: https://tomesphere.com/paper/PMC12956330